Mutant Rab24 GTPase is targeted to nuclear inclusions
© Maltese et al; licensee BioMed Central Ltd. 2002
Received: 8 July 2002
Accepted: 25 September 2002
Published: 25 September 2002
Members of the Rab GTPase family regulate intracellular protein trafficking, but the specific function of Rab24 remains unknown. Several attributes distinguish this protein from other members of the Rab family, including a low intrinsic GTPase activity.
The functions of other Rab proteins have been defined through the use of dominant-negative mutants with amino acid substitutions in the conserved N(T)KxD nucleotide binding motif. Surprisingly, when such Rab24 constructs were expressed in cultured cells, they accumulated in nuclear inclusions which disrupted the integrity of the nuclear envelope. The inclusions reacted positively with antibodies against ubiquitin and Hsp70, similar to protein aggregates observed in polyglutamine disorders. They also appeared to sequester importin-β and GFP-coupled glucocorticoid receptor. Other Rab GTPases with similar mutations in the N(T)KxD motif were never found in inclusions, suggesting that the unusual localization of Rab24 is not related solely to misfolding of its nucleotide-free form. Studies with Rab24/Rab1B chimeras indicated that targeting of the mutant protein to inclusions requires the unique C-terminal domain of Rab24.
These studies demonstrate that mutations in Rab24 can trigger a cytopathic cellular response involving accumulation of nuclear inclusions. If the N(T)KxD mutants of Rab24 function as dominant suppressors, these studies may point to a unique role for Rab24 in degradation of misfolded cellular proteins or trafficking of proteins to the nuclear envelope. However, we cannot yet eliminate the possibility that these phenomena are related to unusual non-physiological protein interactions with the mutant form of Rab24.
Rab proteins comprise a large family of Ras-related GTPases that function in the anterograde and retrograde trafficking of proteins in mammalian cells [1–3]. Different Rab proteins reside in specific subcellular membranes or organelles, where they mediate vesicular transport between discrete donor and acceptor compartments in the endocytic or exocytic pathways [4, 5]. Detailed studies of a few Rab proteins (e.g.; Rab1, Rab5 and Rab9) have led to a general model wherein Rab proteins are presumed to cycle on and off donor and acceptor membranes in connection with changes in their guanine nucleotide state [6–8]. In the active GTP-bound state, Rab proteins associate with budding transport vesicles [9–11] and appear to participate in the assembly of membrane docking complexes [12–14]. Following vesicle fusion with the acceptor compartment and GTP hydrolysis, the inactive GDP-bound Rab is extracted from the membrane by a carrier protein termed guanine nucleotide dissociation inhibitor (GDI) [15–17]. The GTPase can then re-enter the transport cycle through nucleotide exchange promoted by a specific exchange factor at the donor vesicle membrane [18–20]. In addition to changes in guanine nucleotide state, the posttranslational prenylation of Rab proteins plays an important role in the cycling mechanism. Non-modified Rabs have a low affinity for GDI [21, 17]and do not associate effectively with membranes [22, 23].
Rab24, originally identified by Olkkonen et al. , remains one of several members of the Rab family without a confirmed biological function. We have described several unusual features of Rab24 that distinguish it from all other members of the Rab family studied to date . Rab24 has a markedly reduced GTPase activity, due primarily to the presence of a serine residue instead of the usual glutamine at the position equivalent to Q61 in H-Ras. Furthermore, Rab24 is not efficiently geranylgeranylated and does not form a detectable complex with GDI. These unique properties of Rab24 suggest that it may not function according to the accepted cyclical model.
In the present study we set out to learn about the biological function of Rab24 by using a well-established paradigm in which a dominant-negative Rab construct is expressed in cultured cells, anticipating that it will suppress the trafficking step(s) mediated by its endogenous counterpart. Amino acid substitutions at the position cognate to N116 in H-Ras typically yield soluble Rab proteins that have a reduced affinity for guanine nucleotides. Such constructs have been used successfully to define the functions of Rab1A and Rab1B [26–28], Rab4 , Rab5 [30, 31] and Rab6 . Unexpectedly, we found that expression of the mutant forms of Rab24 in cultured cells resulted in their accumulation in a striking array of insoluble intranuclear inclusions which disrupt the integrity of the nuclear envelope.
Mutant forms of Rab24 accumulate in nuclear inclusions
In all of the known Ras-related GTPases the guanine nucleotide binding site is surrounded by a set of highly conserved sequence elements [33, 34]. One of these elements, termed the G2 motif, consists of NKxD (with the asparagine located at position 116 in H-Ras). In Rab24, and in some members of the Rho family, threonine occurs instead of the asparagine. Amino acid substitutions in the N(T)KxD motif cause a drastic reduction in the affinity of Ras-related GTPases for guanine nucleotides [35, 36]. When overexpressed in cultured cells, these mutant GTPases function as dominant-suppressors of their endogenous counterparts [26, 27, 31], presumably because they can compete for interaction with effectors, exchange factors or docking proteins, but cannot cycle on and off membranes in a nucleotide-dependent manner. We set out to assess the function of Rab24 by making substitutions in its TKxD motif, starting with D123--->I. To facilitate localization of the proteins, the wild-type and mutant constructs were made with a myc-epitope tag at the amino terminus. The addition of such tag sequences to Ras-related proteins, including several members of the Rab family, does not appear to alter their function or subcellular localization [36–38].
Western blot analyses of cytosol and particulate fractions obtained from the transfected 293 cells indicated that mycRab24(wt) was present in both fractions, consistent with previous results with Rab24 and other wild-type Rab GTPases [25, 39]. In contrast, mycRab24(D123I) was found exclusively in the particulate fraction (Fig. 1C). When transfected cells were disrupted in a buffer containing 0.5% NP-40, 0.5% deoxycholate and 0.1% SDS, most of the Rab24(D123I) was recovered in the detergent-insoluble fraction (Fig. 1D). This suggested that the mutant protein was concentrated in inclusion bodies rather than membrane components.
Rab24 is known to be expressed endogenously in many cell types, including the cell lines used in these studies [24, 25], and we have estimated that both mycRab24wt and D123I are transiently expressed 5–10 fold over the level of endogenous Rab24 (data not shown). Therefore, a question raised by these studies is whether the genesis of nuclear inclusions occurs indirectly, through dominant suppression of endogenous Rab24 function by the D123I and T120A mutants, or directly, through association of cellular proteins with the accumulating mutant protein. We attempted to distinguish between these possibilities by using an alternative strategy to make a dominant-negative form of Rab24. Several laboratories have shown that in addition to mutations in the N(T)KxD motif, which reduce overall nucleotide binding, dominant-negative Rab constructs can be generated by introducing amino acid substitutions (e.g., asparagine) at the position cognate to Ras S17 (i.e., S22 in Rab24) [31, 40–42]. Such proteins are thought to be locked in an inactive GDP-bound state because the mutation markedly reduces their affinity for GTP, compared to GDP . As shown in Fig. 2B, when mycRab24(S22N) was expressed in 3T3 cells, there was no evidence of nuclear inclusions. However, when the bound 32P-labeled nucleotides associated with the expressed protein were analyzed by thin-layer chromatography (Fig. 2C), we were surprised to find that the S22N mutant was predominantly in the GTP-bound state. The inability of the S22N substitution to substantially reduce the affinity of Rab24 for GTP adds to the growing list of fundamental differences between Rab24 and other members of the Rab family. In a previous study we observed that replacing S67 with Q (which occupies this position all other Rab proteins) increases the GTPase activity of Rab24 , resulting in a modest increase in the ratio of protein in the GDP versus GTP state (see Fig. 2C). When this mutant was expressed in 3T3 cells we again failed to observe inclusion bodies (Fig. 2B). Since neither Rab24(S22N) nor Rab24(S67Q) showed evidence of being locked in a GDP-bound state, it is unlikely that either would function as a dominant-negative. Thus, the question of whether the nuclear inclusions containing the D123I and T120A mutants are caused by dominant-negative suppression of endogenous Rab24 function remains to be resolved.
Morphological characteristics of the nuclear inclusions
Disruption of nuclear architecture by inclusions containing Rab24(D123I)
Rab24(D123I) disrupts nuclear import of glucocorticoid receptor
The C-terminal hypervariable domain of Rab24 is required for the formation of inclusions
The second region where the sequence of Rab24 differs substantially from other Rab GTPases is the last 38 amino acids of the C-terminal tail. This region, commonly referred to as the hypervariable domain, plays a major role in the subcellular targeting and functional specificity of each Rab protein . In accord with this view, replacement of the hypervariable domain of Rab24(wt) with the corresponding domain from Rab1B, caused the resulting chimera to exhibit a discrete juxtanuclear Golgi-like fluorescence pattern typical of Rab1B in 293 cells [50, 51]. (Fig. 8C). When the D123I substitution was introduced into the Rab24 portion of the Rab24/Rab1B chimera, the protein was no longer targeted to inclusion bodies (Fig. 8D), but instead exhibited a diffuse distribution similar to Rab1B(N121I) and other Rabs with mutations in the N(T)KxD motif (see Fig. 2). To confirm the importance of the Rab24 hypervariable domain for targeting to inclusion bodies, we performed the reciprocal experiment, replacing the C-terminal domain of Rab1B(wt) or Rab1B(N121I) with the hypervariable domain from Rab24. Instead of the usual Rab1B juxtanuclear Golgi localization, the Rab1B(wt)/Rab24 chimera showed a broader cytoplasmic distribution similar to that of Rab24(wt) (Fig. 8E). Most notably, replacement of hypervariable domain of Rab1B(N121I) with the corresponding C-terminal region from Rab24 caused a major change in the localization of the chimera from a predominant cytoplasmic distribution typical of Rab1B(N121I) (Fig. 2) to a pattern of large intranuclear and cytoplasmic inclusion bodies (Fig. 8F).
Nuclear inclusions generated by Rab24(D123I) contain ubiquitin and Hsp70
Here we have shown that single amino acid substitutions (e.g., D123I and T120A) in one of the conserved guanine nucleotide binding domains of Rab24 can cause the protein to accumulate in a massive array of nuclear inclusions in mammalian cells. Although members of the Ras GTPase superfamily have been studied for many years using site-directed mutagenesis approaches, there have been no previous reports demonstrating cytopathic effects of this kind. In particular, as we have shown in Fig. 2, a variety of Rab proteins bearing similar mutations are localized in the cytoplasmic compartment.
It remains unclear whether the nuclear inclusions induced by Rab24(D123I) are generated de novo inside the nucleus or instead penetrate the nuclear membrane after being assembled in the cytoplasmic compartment. Rab24 does not have a classic nuclear localization signal sequence, but monomeric mycRab24(D123I) is theoretically small enough (24 kDa) to diffuse across the nuclear pores . However, it is less likely that this could occur in the case of the larger EGFP-Rab24(D123I) fusion construct (50 kDa), which also formed abundant intranuclear inclusions (Fig. 9). Our preliminary observations indicate that some of the intranuclear inclusions containing Rab24(D123I) are immunoreactive for lamins, while those outside the nucleus are not (Fig. 4B). Moreover, the electron micrographs show that nuclei containing clusters of inclusions often have regions where the nuclear membrane appears to be discontinuous (Fig. 3C). Based on these findings, we believe that aggregates formed in the cytoplasm may transiently associate with and disrupt the nuclear envelope, then enter the nucleus through the resulting gaps. Ultimately, the accumulation of nuclear inclusions in cells expressing Rab24(D123I) causes a catastrophic disruption of the nuclear architecture, although this does not appear to be accompanied by classic signs of apoptotic cell death such as DNA fragmentation or caspase activation.
The molecular mechanism underlying the formation of nuclear inclusions in cells expressing the mutant forms of Rab24 remains to be defined. An extensive body of published work supports the notion that Rab proteins bearing mutations in the N(T)KxD nucleotide binding motif function as dominant-suppressors of their endogenous cellular counterparts. Our domain-exchange experiments with Rab24 and Rab1B (Fig. 8) indicate that incorporation of the mutant proteins into nuclear inclusions requires the specific C-terminal hypervariable targeting domain of Rab24. Therefore, one possibility is that the inclusions arise as a consequence of disruption of the normal physiological function of Rab24. To explore this issue further, we attempted to generate another potential dominant-negative form of Rab24, predicted to be locked in the GDP state. However, when we made the amino acid substitution customarily used to generate such Rab mutants (i.e., S22N), Rab24 unexpectedly remained in the GTP state. Therefore, pending further investigation, we cannot rule out the alternative hypothesis that mutations in the N(T)KxD motif of Rab24, combined with features in the C-terminal domain, cause Rab24 to misfold in a unique manner, attracting non-physiological protein partners that can promote aggregation and nuclear localization.
As a framework for future studies we can envision at least three models that could explain the accumulation of inclusion bodies in cells expressing Rab24(D123I). Our immunofluorescence studies (Fig. 10) suggest that the inclusions are complex protein assemblies containing Hsp70 and ubiquitin. Therefore, the first possibility is that the presence of Hsp70 and ubiquitin reflects a failed attempt by the cell to eliminate misfolded protein aggregates via the proteasome pathway. Indeed, a similar explanation has been invoked to explain the presence of Hsp70 and ubiquitin in nuclear aggregates observed in cells expressing abnormal gene products with poly-Gln tracts, such as huntingtin  and ataxin-1 . Based on reports that overexpression of chaperones [59, 62] or a dominant-negative form of the ubiquitin-conjugating enzyme  can suppress the formation of poly-Gln protein aggregates, Kaytor and Warren  proposed a three-stage model wherein (i) molecular chaperones initially associate with the misfolded protein, (ii) failure to diminish the pool of misfolded protein leads to aggregation and ubiquitination and (iii) inefficient degradation of the aggregate by the proteasome is manifested by the accumulation of inclusion bodies. Although this model implies that the misfolded poly-Gln protein might be the primary substrate for ubiquitination, a recent study by Suhr et al.  suggests that this may not always be the case. Specifically, they found that when aggregates from 293 cells expressing poly-Gln proteins were dissociated, the ubiquitin polymers were not conjugated directly to the poly-Gln protein or the sequestered Hsp70.
An alternative mechanism for the formation of inclusion bodies in protein conformation disorders is suggested by a recent study showing that clearance of poly-Gln and poly-Ala inclusions is accelerated by compounds like rapamycin, which stimulate protein degradation by autophagy . Along similar lines, the work of Kegel et al.  hints that poly-Gln huntingtin may be degraded mainly in autophagic vacuoles containing lysosomal proteases. Interestingly, Rab24 has been implicated as a possible mediator of autophagy in a recent study where wild-type GFP-Rab24 was observed to accumulate on large autophagic vacuoles in cells subjected to amino acid starvation . Thus, if Rab24(D123I) functions as a true dominant suppressor of endogenous Rab24, the inclusions observed in the present study may consist of misfolded endogenous proteins that cannot be degraded because basal activity of the autophagosome-lysosome pathway is blocked.
Although the two preceding models may explain the presence of Hsp70 and ubiquitin in the Rab24(D123I)-induced aggregates, the incorporation of glucocorticoid receptor (Fig. 6) and importin-β (Fig. 7) may point to a third distinct scenario. Aside from its well-characterized role in protein folding , Hsp70 is known to associate with the GR in the cytoplasm, where it promotes formation of a heterocomplex between the inactive GR and Hsp90 . In addition, Hsp70 becomes concentrated in the nucleus when cells are exposed to environmental stress . Of particular note, the nuclear accumulation of the Hsp70, Ssa4p, in response to nutrient deprivation in yeast appears to occur by a novel mechanism that involves its direct interaction with Mmd5p, a member of the importin-β family . A role for Rab24 in nuclear trafficking would be unanticipated, since the only GTPase known to function in nuclear import/export (Ran) is structurally distinct from the Rab subgroup of the Ras superfamily [70, 71]. Nevertheless, we can speculate that if Rab24 participates in a stress-induced pathway for nuclear import of Hsp70 in mammalian cells, the constitutive overexpression of Rab24(D123I) might stimulate aberrant accumulation of Hsp70/importin-β aggregates at the nuclear pore complex. This might ultimately result in disruption of the nuclear envelope and penetration of the aggregates into the nucleus. If the Hsp70 in these aggregates retains the capacity to bind GR, this could account for the sequestration of nascent GR in these structures.
It is well established that mutations affecting the guanine nucleotide state of Ras are associated with neoplastic transformation of mammalian cells [35, 72, 73]. However, the potential role of Rab mutations in disease is just beginning to be explored. Menasche et al.  found mutations in the Rab27A gene in 16 patients with Griscelli's syndrome, an autosomal recessive disorder characterized by defects in skin pigmentation and T-lymphocyte and macrophage activation. While several of the mutations were deletions, a few were missense mutations that changed single amino acids in conserved regions of the Rab structure. Mutations in the Rab27A gene have also been detected in mice with the coat color mutation ashen, which is regarded as a model for Griscelli's syndrome [75, 76]. Rab24 can be detected in many tissues and cell lines [24, 25], but expression appears to be highest in neuronal cells . At present there are no available data specifically linking Rab24 mutations to human disease. However, there are many case reports describing patients with progressive neurodegenerative disorders of unknown etiology, collectively referred to as neuronal intranuclear inclusion disease . While these may consist mainly of unidentified poly-Gln or poly-Ala disorders, the present study raises the possibility that some forms of this disease may arise through unexpected mechanisms, perhaps involving mutations in Rab24 or other poorly characterized members of the Rab GTPase family that mediate trafficking of misfolded proteins within autophagosomes and lysosomes.
Previous studies have shown that Rab24 exhibits several unusual characteristics that distinguish it from other members of the Rab GTPase family . The studies described in this report demonstrate that putative dominant-negative mutant forms of Rab24, bearing single amino acid substitutions in the conserved N(T)KxD nucleotide binding motif (e.g., D123I and T120A), are targeted to numerous inclusion bodies that disrupt the nuclear envelope and enter the nuclear compartment. The inclusions bear a superficial resemblance to those described in some of the polyglutamine disorders, and appear to sequester Hsp70, ubiquitin, importin-β, and glucocorticoid receptor. Studies of Rab24/Rab1B chimeras indicate that the unusual cytopathic effects induced by the D123I mutant require sequence elements within the Rab24 C-terminal hypervariable targeting domain. Similar mutations in the N(T)KxD motif of other Rab proteins typically yield soluble cytoplasmic proteins. Confirmatory studies with other potential dominant-negative mutants, such as those bearing substitutions at the position cognate to Ras S17, were not possible with Rab24, because such mutants remained in the GTP state. The present results further highlight the unique nature of Rab24 and raise the possibility that it may function in autophagic degradation of misfolded proteins, or perhaps play an unanticipated role in nuclear protein trafficking or maintenance/assembly of the nuclear envelope.
The cDNA encoding Rab24 was obtained by PCR amplification from first strand cDNA template reverse-transcribed from mouse brain mRNA, using Taq DNA polymerase (Perkin Elmer). Oligonucleotide primers for the PCR reaction were based on the published sequence of murine Rab24 . Kpn1 and BamH1 restriction sites were added to the 5' and 3' primers respectively, to facilitate cloning of the PCR product in frame with a 5' sequence cassette encoding a myc epitope (EQKLISEEDL), previously introduced into the pCMV5 expression vector . The Rab24 cDNA was altered by overlap-extension PCR , using appropriate mutator oligonucleotides and Pfu DNA polymerase (Stratagene Inc., La Jolla, CA), so as to introduce amino acid substitutions at D123 (D123I), T120 (T120A), S22 (S22N), S67 (S67Q), and a deletion of residues 127 through 130 (ΔEDRR). The cDNA encoding human Rab11 was obtained by PCR amplification from first strand cDNA template, reverse-transcribed from Hela cell mRNA. This sequence was cloned into pCMV5, in-frame with a 5' myc epitope tag sequence, and altered to encode the N124I substitution as stated above for Rab24. Other pCMV5 expression vectors encoding Rab1B(N121I) , Rab6(N126I) and Rab8(N121I)  have been described in the indicated references. pCMV5 expression vectors containing Rab24 and Rab1B were engineered by overlap-extension PCR to encode the following chimeric proteins: Rab24/Rab1B, consisting of residues 1–165 of Rab24  fused to residues 163–201 from Rab1B ; Rab24(D123I)/Rab1B, consisting of residues 1–165 of Rab24 with the D123I substitution, fused to residues 163–201 of Rab1B; Rab1B/Rab24, consisting of residues 1–162 of Rab1B fused to residues 166–203 of Rab24; and Rab1B(N121I)/Rab24, consisting of residues 1–162 of Rab1B with the N121I substitution, fused to residues 166–203 of Rab24. To generate Rab24 fusions with Enhanced Green Fluorescent Protein (EGFP), cDNAs encoding full-length Rab24(wt) or Rab24(D123I), or the Rab24 C-terminal hypervariable domain (residues 166–203) were generated with flanking KpnI and BamHI sites and subcloned into pEGFP-C1 (Clontech Inc., Palo Alto, CA) so that the Rab inserts were in-frame with a 5' EGFP coding sequence. The sequences of all constructs were verified by automated DNA sequencing using a Beckman CEQ2000 system.
Cell culture and transfection
Human embryonal kidney (HEK) cells (line 293) and NIH 3T3 mouse fibroblasts were obtained from American Type Culture Collection (Rockville, MD) and were maintained at 37°C in a 5% CO2 atmosphere in Dulbecco's modified Eagle's medium containing 10% (v/v) fetal bovine serum. On the day before transfection, cells were plated in 6 cm diameter dishes at 5 × 105 cells/dish or in 10 cm diameter dishes at 2 × 106 cells/dish. Cells were transfected with the indicated expression vectors, using Lipofectamine Plus reagent (Life Technologies, Inc., Rockville, MD) for 293 cells or Superfect reagent (Qiagen, Valencia, CA) for 3T3 cells, according to the protocols recommended by the manufacturers.
Subcellular distribution of Rab24
To determine the subcellular distribution of mycRab24(wt) and mycRab24(D123I), 293 cells were plated in 10 cm dishes and transfected with the indicated expression vectors. After 24 h, the cells were harvested in PBS, collected by centrifugation, and lysed in 5 volumes of 40 mM Tris-HCl, pH 7.4, containing complete mini-EDTA-free protease inhibitor cocktail (Sigma, St. Louis, MO). Soluble and particulate fractions were obtained by centrifuging the cell lysate at 100,000 × g for 60 min at 4°C. One quarter of each fraction was subjected to SDS-PAGE and immunoblot analysis using the 9E10 monoclonal antibody against the myc epitope (Oncogene Research Products, Cambridge, MA), followed by HRP-conjugated goat anti-mouse IgG and ECL detection reagent (Amersham Corp, Arlington Hts., IL) as described previously [50, 81]. To determine the detergent solubility of the Rab24(D123I) mutant, transfected cells from a 10 cm culture dish were homogenized in 0.2 ml of 100 mM Tris-HCl, pH 7.4, containing 0.5% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, and 2 mM EDTA. Samples were partitioned into soluble and particulate components and the latter were subjected to SDS-PAGE and immunoblot analysis.
Rab24 guanine nucleotide state
To assess the guanine nucleotide state of selected mycRab24 proteins, cells were transfected with the indicated constructs and incubated with 32P-orthophosphate for 5 h, starting 24 h after transfection. Radiolabeled mycRab24 was immunoprecipitated and the 32P-labeled guanine nucleotides eluted from the protein were subjected to thin-layer chromatography to resolve GDP and GTP. Aliquots of the immunoprecipitated protein were also subjected to immunoblot analysis with antibody against the myc epitope, so that the amount of bound nucleotide could be related to the amount of protein. A detailed description of these procedures has been published previously .
HEK293 cells or NIH3T3 cells were seeded on laminin-coated coverslips in 60 mm dishes and transfected as described above. Cells were fixed for 15 min in 3% (w/v) paraformaldehyde, rinsed for 5 min with 0.05 M NH4Cl2, permeabilized for 2 min with 0.1% (v/v) TritonX-100, and blocked for 30 min with 0.1% (w/v) BSA. All solutions were prepared in PBS. To detect the expressed myc-tagged Rab proteins, cells were incubated for 60 min with either the 9E10 mouse monoclonal antibody against the myc epitope or a rabbit polyclonal antibody against the same epitope (Upstate Biotechnology, Lake Placid, NY). In some experiments nuclei were visualized by counter-staining with 4',6'-diamidino-2-phenylindole (DAPI) (2 μg/ml) (Molecular Probes, Eugene, OR). Other monoclonal antibodies used in combination with the rabbit anti-myc antibody were: anti-lamin A + B and anti-ubiquitin (Zymed Laboratories, South San Francisco, CA), anti-Hsp70 and anti-Hsp90 (Stressgen, Inc., Victoria, BC, Canada), anti-GFP (Clontech, Inc. Palo Alto, CA), anti-karyopherin β and anti-Ran binding protein (Transduction Laboratories, Lexington, KY). Depending on the combination of primary antibodies, cells were incubated for 60 min with goat anti-mouse (GAM) or goat anti-rabbit (GAR) IgG's conjugated with either FITC or rhodamine (Sigma Chemical Co., Louis, MO). Photomicrographs were taken with a Nikon Eclipse 800 fluorescence microscope equipped with a digital camera and ImagePro software (Media Cybernetics, Silver Spring, MD). In some cases, gray scale images were pseudo-colored to correspond to the red (Rhodamine), green (FITC) or blue (DAPI) fluorescence, and the digital images were merged.
Nuclear translocation of glucocorticoid receptor
The expression vector pK7-GR-GFP , which encodes a fusion of the glucocorticoid receptor (GR) with green fluorescent protein (GFP), was provided by Dr. Ian Macara, University of Virginia, Charlottesville, USA. NIH 3T3 cells were seeded on glass coverslips in DMEM containing 10% charcoal-stripped FCS, without phenol red. Twenty four hours after transfection, the cells were changed to fresh medium with or without 1 μM dexamethasone (Dex). All cells were fixed for immunofluorescence microscopy 10 min after addition of Dex. The localization of GR-GFP was determined in comparison to mycRab24, detected with anti-myc monoclonal antibody and rhodamine-conjugated GAM-IgG, as described above.
Transfected cells were washed twice with PBS and scraped from the dish using a rubber policeman. The resulting cell suspensions were centrifuged in Eppendorf® tubes and cell pellets were fixed for 5 min at room temperature using a 1% glutaraldehyde in 0.2M sodium cacodylate, pH 7.2. Fixed cell pellets were washed twice with cacodylate buffer and twice with 0.5 M ammonium chloride. Each sample was dehydrated via a graded series of chilled ethanol solutions and infiltrated and embedded in LR White® Embedding media (London Resin Co., Ltd., Berkshire, England), also at 2°C. Polymerized cell blocks were ultra-thin sectioned with a Reichert Ultracut S ultramicrotome (Leica Microsystems, Wien, Austria) and sections collected on gold 200-mesh electron microscopy support grids. Sections were incubated with PBS for 5 min, then blocked in a solution of 10% fish gelatin in PBS for 15 minutes. Reaction with the 9E10 mouse anti-myc antibody (1:100 dilution in PBS) was carried out for 2 h, followed by 6 washes with PBS. Sections were then incubated for 1 h with GAM IgG conjugated with 10 nm colloidal gold (Ted Pella, Inc., Redding, CA), followed by 3 changes of PBS. The samples were post-fixed with 1% glutaraldehyde and stained with uranyl acetate and lead citrate. They were then blot-dried and examined with a Philips CM 10 transmission electron microscope for localization of the colloidal gold probe.
Solubilization of Rab24(D123I) from inclusions and assay for ubiquitination
The cDNAs encoding Rab24(wt) and Rab24(D123I) were subcloned into a pCMV5 vector that had been modified by PCR to encode an in-frame polyhistidine tag (His6) at the amino-terminus of the Rab protein. HEK 293 cells grown in 10 cm diameter dishes were transfected with either pCMV5-His6Rab24 or pCMV5-His6Rab24(D123I) as described earlier. 20 μM lactacystin (Sigma, St. Louis, MO) was added to the medium 18 h after transfection and cells were incubated with the proteasome inhibitor for 4 h prior to harvest. Cells were scraped from the dish, collected by centrifugation, and homogenized in 0.25 ml Buffer A: 0.15 M NaCl, 20 mM MgCl2, 0.05% (w/v) SDS, 20 mM HEPES, pH 7.4, supplemented with protease inhibitor cocktail. The cell lysate was mixed with 0.25 ml of Buffer B (Buffer A containing 1% NP-40 and 1% deoxycholate) and the insoluble material was removed by centrifugation at 100,000 × g for 30 min. The supernatant fraction was diluted 1:1 with Buffer C (Buffer A containing 0.5% NP-40 and 0.5% deoxycholate, with no SDS) and loaded on to a Ni-NTA spin column (Qiagen). The column was washed with Buffer D (0.15 M NaCl, 20 mM MgCl2, 0.025% SDS, 0.5% deoxycholate, 0.5% NP-40, 20 mM HEPES, pH 7.4) and the His6-tagged protein was eluted with Buffer D containing 0.25 M imidazole. Samples of the eluted protein were subjected to SDS-PAGE and immunoblot analysis as described previously, using a polyclonal antibody against Rab24 , or monoclonal antibodies against the His6-tag (Sigma) or ubiquitin (Zymed Laboratories).
Cell death assay
Cells were transfected with pCMV5 expression vectors encoding mycRab24(D123I) as described earlier. DNA fragmentation was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay, using fluorescein-12-dUTP, according to the instructions supplied by the manufacturer (Promega Corp., Madison, WI). Following the TUNEL reaction, the cells were incubated with monoclonal anti-myc antibody and Rhodamine-conjugated GAM IgG to detect the expressed Rab protein. Fluorescence microscopy was used to determine the number of transfected cells that were TUNEL-positive, compared to non-transfected cells in the same culture. As a positive control for apoptosis, parallel cultures were treated for 24 h with 1 μM staurosporine.
The authors thank Kelly Bromfield for cloning Rab11 and Kathleen Shellenberger for making the Rab24 D123I construct. This work was supported by National Institutes of Health grant CA34569 to W.A.M.
- Chavrier P, Simons K, Zerial M: The complexity of the rab and rho GTP-binding protein subfamilies revealed by a PCR cloning approach. Gene. 1992, 112: 261-264. 10.1016/0378-1119(92)90387-5.View ArticlePubMed
- Martinez O, Goud B: Rab proteins. Biochim Biophys Acta. 1998, 1404: 101-112. 10.1016/S0167-4889(98)00050-0.View ArticlePubMed
- Pereira-Leal JB, Seabra MC: The mammalian Rab family of small GTPases: Definition of family and subfamily sequence motifs suggests a mechanism for functional specificity in the Ras superfamily. J Mol Biol. 2000, 301: 1077-1087. 10.1006/jmbi.2000.4010.View ArticlePubMed
- Simons K, Zerial M: Rab proteins and the road maps for intracellular transport. Neuron. 1993, 11: 789-799.View ArticlePubMed
- Somsel RJ, Wandinger-Ness A: Rab GTPases coordinate endocytosis. J Cell Sci. 2000, 113: 183-192.
- Nuoffer C, Balch WE: GTPases: Multifunctional molecular switches regulating vesicular traffic. Annu Rev Biochem. 1994, 63: 949-990. 10.1146/annurev.biochem.63.1.949.View ArticlePubMed
- Novick P, Zerial M: The diversity of Rab proteins in vesicle transport. Curr Opin Cell Biol. 1997, 9: 496-504. 10.1016/S0955-0674(97)80025-7.View ArticlePubMed
- Schimmoller F, Simon I, Pfeffer SR: Rab GTPases, Directors of vesicle docking. J Biol Chem. 1998, 273: 22161-22164. 10.1074/jbc.273.35.22161.View ArticlePubMed
- Christoforidis S, McBride HM, Burgoyne RD, Zerial M: The Rab5 effector EEA1 is a core component of endosome docking. Nature. 1999, 397: 621-625. 10.1038/17618.View ArticlePubMed
- Nielsen E, Christoforidis S, Uttenweiler-Joseph S, Miaczynska M, Dewitte F, Wilm M, Hoflack B, Zerial M: Rabenosyn-5, a Novel Rab5 Effector, Is Complexed with hVPS45 and Recruited to Endosomes through a FYVE Finger Domain. J Cell Biol. 2000, 151: 601-612. 10.1083/jcb.151.3.601.PubMed CentralView ArticlePubMed
- Diaz E, Schimmoller F, Pfeffer SR: A novel Rab9 effector required for endosome-to-TGN transport. J Cell Biol. 1997, 138: 283-290. 10.1083/jcb.138.2.283.PubMed CentralView ArticlePubMed
- Sogaard M, Tani K, Ye RR, Geromanos S, Tempst P, Kirchhausen T, Rothman JE, Sollner T: A Rab protein is required for the assembly of SNARE complexes in the docking of transport vesicles. Cell. 1994, 78: 937-948.View ArticlePubMed
- Waters MG, Pfeffer SR: Membrane tethering in intracellular transport. Curr Opin Cell Biol. 1999, 11: 453-459. 10.1016/S0955-0674(99)80065-9.View ArticlePubMed
- Allan BB, Moyer BD, Balch WE: Rab1 recruitment of p115 into a cis-SNARE complex: programming budding COPII vesicles for fusion. Science. 2000, 289: 444-448. 10.1126/science.289.5478.444.View ArticlePubMed
- Ullrich O, Stenmark H, Alexandrov K, Hubar LA, Kaibuchi K, Sasaki T, Takai Y, Zerial M: Rab GDP dissociation inhibitor as a general regulator for the membrane association of rab proteins. J Biol Chem. 1993, 268: 18143-18150.PubMed
- Pfeffer SR, Dirac-Svejstrup AB, Soldati T: Rab GDP dissociation inhibitor: Putting Rab GTPases in the right place. J Biol Chem. 1995, 270: 17057-17059. 10.1074/jbc.270.29.17057.View ArticlePubMed
- Soldati T, Riederer MA, Pfeffer SR: Rab GDI: A solubilizing and recycling factor for rab9 protein. Mol Biol Cell. 1993, 4: 425-434.PubMed CentralView ArticlePubMed
- Dirac-Svejestrup AB, Sumizawa T, Pfeffer SR: Identification of a GDI displacement factor that releases endosomal Rab GTPases from Rab-GDI. EMBO J. 1997, 16: 465-472. 10.1093/emboj/16.3.465.View Article
- Horiuchi H, Giner A, Hoflack B, Zerial M: A GDP/GTP exchange-stimulatory activity for the Rab5-RabGDI complex on clathrin-coated vesicles from bovine brain. J Biol Chem. 1995, 270: 11257-11262. 10.1074/jbc.270.19.11257.View ArticlePubMed
- Wada M, Nakanishi H, Satoh A, Hirano H, Obaishi H, Matsuura Y, Takai Y: Isolation and characterization of a GDP/GTP exchange protein specific for the Rab3 subfamily small G proteins. J Biol Chem. 1997, 272: 3875-3878. 10.1074/jbc.272.7.3875.View ArticlePubMed
- Musha T, Kawata M, Takai Y: The geranylgeranyl moiety but not the methyl moiety of the smg25A/rab3A protein is essential for the interactions with membrane and its inhibitory GDP/GTP exchange protein. J Biol Chem. 1992, 267: 9821-9825.PubMed
- Khosravi-Far R, Lutz RJ, Cox AD, Conroy L, Bourne JR, Sinensky M, Balch WE, Buss JE, Der CJ: Isoprenoid modification of rab proteins terminating in CC or CXC motifs. Proc Natl Acad Sci U S A. 1991, 88: 6264-6268.PubMed CentralView ArticlePubMed
- Overmeyer JH, Maltese WA: Isoprenoid requirement for intracellular transport and processing of murine leukemia virus envelope protein. J Biol Chem. 1992, 267: 22686-22692.PubMed
- Olkkonen VM, Dupree P, Killisch I, Lutcke A, Zerial M, Simons K: Molecular cloning and subcellular localization of three GTP-binding proteins of the rab subfamily. J Cell Sci. 1993, 106: 249-261.
- Erdman RA, Shellenberger KE, Overmeyer JH, Maltese WA: Rab24 is an atypical member of the Rab GTPase family. Deficient GTPase activity, GDP dissociation inhibitor interaction, and prenylation of Rab24 expressed in cultured cells. J Biol Chem. 2000, 275: 3848-3856. 10.1074/jbc.275.6.3848.View ArticlePubMed
- Tisdale EJ, Bourne JR, Khosravi-Far R, Der CJ, Balch WE: GTP-binding mutants of rab1 and rab2 are potent inhibitors of vesicular transport from the endoplasmic reticulum to the Golgi complex. J Cell Biol. 1992, 119: 749-761.View ArticlePubMed
- Pind SN, Nuoffer C, McCaffery JM, Plutner H, Davidson HW, Farquhar MG, Balch WE: Rab1 and Ca2+ are required for the fusion of carrier vesicles mediating endoplasmic reticulum to Golgi transport. J Cell Biol. 1994, 125: 239-252.View ArticlePubMed
- Dugan JM, deWit C, McConlogue L, Maltese WA: The ras-related GTP binding protein, Rab1B, regulates early steps in exocytic transport and processing of β-amyloid precursor protein. J Biol Chem. 1995, 270: 10982-10989. 10.1074/jbc.270.18.10982.View ArticlePubMed
- van der Sluijs P, Hull M, Webster P, Male P, Goud B, Melman I: The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway. Cell. 1992, 70: 729-740.View ArticlePubMed
- Bucci C, Parton RG, Mather IH, Stunnenberg H, Simons K, Hoflack B, Zerial M: The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell. 1992, 70: 715-728.View ArticlePubMed
- Li G, Stahl PD: Structure-function relationship of the small GTPase rab5. J Biol Chem. 1993, 268: 24475-24480.PubMed
- McConlogue L, Castellano F, deWit C, Schenk D, Maltese WA: Differential effects of a Rab6 mutant on secretory versus amyloidogenic processing of Alzheimer's β-amyloid precursor protein. J Biol Chem. 1996, 271: 1343-1348. 10.1074/jbc.271.3.1343.View ArticlePubMed
- Valencia A, Kjeldgaard M, Pai EF, Sander C: GTPase domains of ras p21 oncogene protein and elongation factor Tu: Analysis of three-dimensional structures, sequence families and functional sites. Proc Natl Acad Sci U S A. 1991, 88: 5443-5447.PubMed CentralView ArticlePubMed
- Valencia A, Chardin P, Wittinghofer A, Sander C: The ras protein family: Evolutionary tree and role of conserved amino acids. Biochemistry. 1991, 30: 4637-4648.View ArticlePubMed
- Der CJ, Pan BT, Cooper GM: rasH mutants deficient in GTP binding. Mol Cell Biol. 1986, 6: 3291-3294.PubMed CentralView ArticlePubMed
- Brondyk WH, McKiernan CJ, Burstein ES, Macara IG: Mutants of rab3A analogous to oncogenic ras3A analogous to oncogenic ras mutants. J Biol Chem. 1993, 268: 9410-9415.PubMed
- Chen YT, Holcomb C, Moor HPH: Expression and localization of two low molecular weight GTP-binding proteins, Rab8 and Rab10, by epitope tag. Proc Natl Acad Sci U S A. 1993, 90: 6508-6512.PubMed CentralView ArticlePubMed
- Beranger F, Cadwallader K, Profiri E, Powers S, Evans T, de Gunzberg J, Hancock JF: Determination of structural requirements for the interaction of Rab6 with RabGDI and Rab geranylgeranyltransferase. J Biol Chem. 1994, 269: 13637-13643.PubMed
- Erdman RA, Maltese WA: Different Rab GTPases associate preferentially with α or β GDP-dissociation inhibitors. Biochem Biophy Res Commun. 2001, 282: 4-9. 10.1006/bbrc.2001.4560.View Article
- Chen W, Feng Y, Chen D, Wandinger-Ness A: Rab11 is required for trans-golgi network-to-plasma membrane transport and a preferential target for GDP dissociation inhibitor. Mol Biol Cell. 1998, 9: 3241-3257.PubMed CentralView ArticlePubMed
- Vitelli R, Santillo M, Lattero D, Chiariello M, Bifulco M, Bruni CB, Bucci C: Role of the small GTPase Rab7 in the late endocytic pathway. J Biol Chem. 1997, 272: 4391-4397. 10.1074/jbc.272.7.4391.View ArticlePubMed
- Nuoffer C, Davidson HW, Matteson J, Meinkoth J, Balch WE: A GDP-bound form of Rab1 inhibits protein export from the endoplasmic reticulum and transport between Golgi compartments. J Cell Biol. 1994, 125: 225-237.View ArticlePubMed
- Munafo DB, Colombo MI: Induction of Autophagy Causes Dramatic Changes in the Subcellular Distribution of GFP-Rab24. Traffic. 2002, 3: 472-482. 10.1034/j.1600-0854.2002.30704.x.View ArticlePubMed
- Seglen PO, Gordon PB: 3-Methyladenine: a specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc Natl Acad Sci U S A. 1982, 79: 1889-1892.PubMed CentralView ArticlePubMed
- Truant R, Cullen B: The arginine-rich domains present in human immunodeficiency virus type 1 tat and rev function as direct importin β-dependent nuclear localization signals. Mol Cell Biol. 1999, 19: 1210-1217.PubMed CentralPubMed
- Palmeri D, Malim M: Importin β can mediate the nuclear import of an arginine-rich nuclear localization signal in the absence of importin α. Mol Cell Biol. 1999, 19: 1218-1225.PubMed CentralPubMed
- Moore MS: Ran and nuclear transport. J Biol Chem. 1998, 273: 22857-22860. 10.1074/jbc.273.36.22857.View ArticlePubMed
- Carey KL, Richards SA, Lounsbury KM, Macara IG: Evidence using a green fluorescent protein-glucocorticoid receptor chimera that the RAN/TC4 GTPase mediates and essential function independent of nuclear protein import. J Cell Biol. 1996, 133: 985-996.View ArticlePubMed
- Chavrier P, Gorvel J-P, Stelzer E, Simons K, Gruenberg J, Zerial M: Hypervariable C-terminal domain of rab proteins acts as a targeting signal. Nature. 1991, 353: 769-772. 10.1038/353769a0.View ArticlePubMed
- Wilson AL, Erdman RA, Maltese WA: Association of Rab1B with GDP-dissociation inhibitor (GDI) is required for recycling but not initial membrane targeting of the Rab protein. J Biol Chem. 1996, 271: 10932-10940. 10.1074/jbc.271.18.10932.View ArticlePubMed
- Overmeyer JH, Wilson AL, Maltese WA: Membrane targeting of a Rab GTPase that fails to associate with rab escort protein (REP) or guanine nucleotide dissociation inhibitor (GDI). J Biol Chem. 2001, 276: 20379-20386. 10.1074/jbc.M101511200.View ArticlePubMed
- Paulson HL, Bonini NM, Roth KA: Polyglutamine disease and neuronal cell death. Proc Natl Acad Sci U S A. 2000, 97: 12957-12958. 10.1073/pnas.210395797.PubMed CentralView ArticlePubMed
- Sathasivam K, Hobbs C, Turmaine M, Mangiarini L, Mahal A, Bertaux F, Wanker EE, Doherty P, Davies SW, Bates GP: Formation of polyglutamine inclusions in non-CNS tissue. Hum Mol Genet. 1999, 8: 813-822. 10.1093/hmg/8.5.813.View ArticlePubMed
- DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N: Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997, 277: 1990-1993. 10.1126/science.277.5334.1990.View ArticlePubMed
- Skinner PJ, Koshy BT, Cummings CJ, Klement IA, Helin K, Servadio A, Zoghbi HY, Orr HT: Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature. 1997, 389: 971-974. 10.1038/40153.View ArticlePubMed
- Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel JL, Fischbeck KH, Pittman RN: Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997, 19: 333-344.View ArticlePubMed
- Becher MW, Kotzuk JA, Sharp AH, Davies SW, Bates GP, Price DL, Ross CA: Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis. 1998, 4: 387-397. 10.1006/nbdi.1998.0168.View ArticlePubMed
- Kaytor MD, Warren ST: Aberrant protein deposition and neurological disease. J Biol Chem. 1999, 274: 37507-37510. 10.1074/jbc.274.53.37507.View ArticlePubMed
- Chai Y, Koppenhafer SL, Bonini NM, Paulson HL: Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J Neurosci. 1999, 19: 10338-10347.PubMed
- Suhr ST, Senut MC, Whitelegge JP, Faull KF, Cuizon DB, Gage FH: Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J Cell Biol. 2001, 153: 283-294. 10.1083/jcb.153.2.283.PubMed CentralView ArticlePubMed
- Gorlich D, Mattaj IW: Nucleocytoplasmic Transport. Science. 1996, 271: 1513-1519.View ArticlePubMed
- Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, Zoghbi HY: Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet. 1998, 19: 148-154. 10.1038/502.View ArticlePubMed
- Saudou F, Finkbeiner S, Devys D, Greenberg ME: Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 1998, 95: 55-66.View ArticlePubMed
- Ravikumar B, Duden R, Rubinsztein DC: Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet. 2002, 11: 1107-1117. 10.1093/hmg/11.9.1107.View ArticlePubMed
- Kegel KB, Kim M, Sapp E, McIntyre C, Castano JG, Aronin N, DiFiglia M: Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci. 2000, 20: 7268-7278.PubMed
- Hartl FU: Molecular chaperones in cellular protein folding. Nature. 1996, 381: 571-579. 10.1038/381571a0.View ArticlePubMed
- Pratt WB, Toft DO: Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev. 1997, 18: 306-360.PubMed
- Welch WJ, Feramisco JR: Nuclear and nucleolar localization of the 72,000-dalton heat shock protein in heat-shocked mammalian cells. J Biol Chem. 1984, 259: 4501-4513.PubMed
- Chughtai ZS, Rassadi R, Matusiewicz N, Stochaj U: Starvation promotes nuclear accumulation of the hsp70 Ssa4p in yeast cells. J Biol Chem. 2001, 276: 20261-20266. 10.1074/jbc.M100364200.View ArticlePubMed
- Clarke PR, Zhang C: Ran GTPase: a master regulator of nuclear structure and function during the eukaryotic cell division cycle?. Trends Cell Biol. 2001, 11: 366-371. 10.1016/S0962-8924(01)02071-2.View ArticlePubMed
- Scheffzek K, Klebe C, Fritz-Wolf K, Kabsch W, Wittinghofer A: Crystal structure of the nuclear Ras-related protein Ran in its GDP-bound form. Nature. 1995, 374: 378-381. 10.1038/374378a0.View ArticlePubMed
- Der CJ, Finkel T, Cooper GM: Biological and biochemical properties of human rasH genes mutated at codon 61. Cell. 1986, 44: 167-176.View ArticlePubMed
- Der CJ, Weissman B, MacDonald MJ: Altered guanine nucleotide binding and H-ras transforming and differentiating activities. Oncogene. 1988, 3: 105-112.
- Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S, Wulffraat N, Bianchi D, Fischer A, Le Deist F: Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet. 2000, 25: 173-176. 10.1038/76024.View ArticlePubMed
- Wilson SM, Yip R, Swing DA, O'Sullivan TN, Zhang Y, Novak EK, Swank RT, Russell LB, Copeland NG, Jenkins NA: A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proc Natl Acad Sci U S A. 2000, 97: 7933-7938. 10.1073/pnas.140212797.PubMed CentralView ArticlePubMed
- Haddad EK, Wu X, Hammer JA, Henkart PA: Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice. J Cell Biol. 2001, 152: 835-842. 10.1083/jcb.152.4.835.PubMed CentralView ArticlePubMed
- Weidenheim KM, Dickson DW: Intranuclear inclusion bodies in an elderly demented woman: a form of intranuclear inclusion body disease. Clin Neuropathol. 1995, 14: 93-99.PubMed
- Andersson S, Davis DL, Dahlback H, Jornvall H, Russell DW: Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J Biol Chem. 1989, 264: 8222-8229.PubMed
- Higuchi R: Using PCR to engineer DNA. In: PCR Technology. Edited by: Ehrlich HA. 1989, Stockton Press, NY, 61-70.
- Vielh E, Touchot N, Zahraoui A, Tavitian A: Nucleotide sequence of a rat cDNA: Rab1B, encoding a Rab1-YPT related protein. Nucleic Acids Res. 1989, 17: 1770-PubMed CentralView ArticlePubMed
- Overmeyer JH, Wilson AL, Erdman RA, Maltese WA: The putative "switch 2" domain of the Ras-related GTPase, Rab1B, plays an essential role in the interaction with Rab escort protein. Mol Biol Cell. 1998, 9: 223-235.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.